Literature DB >> 1713641

Prediction of lymph node involvement in breast cancer.

.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1713641

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor.

Authors:  Eckart Laack; Haleh Nikbakht; Anja Peters; Christian Kugler; Yvonne Jasiewicz; Lutz Edler; Dieter Kurt Hossfeld; Udo Schumacher
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

2.  DNA ploidy and helix pomatia lectin binding as predictors of regional lymph node metastases and prognostic factors in breast cancer.

Authors:  M Noguchi; M Thomas; H Kitagawa; K Kinishita; S Kinami; H Takamura; I Miyazaki; Y Mizukami
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

3.  Further analysis of predictive value of Helix pomatia lectin binding to primary breast cancer for axillary and internal mammary lymph node metastases.

Authors:  M Noguchi; M Thomas; H Kitagawa; K Kinoshita; N Ohta; M Nagamori; I Miyazaki
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

4.  Helix pomatia and prognosis of breast cancer.

Authors:  R A Walker
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

5.  Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation.

Authors:  A Thies; I Moll; J Berger; U Schumacher
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

6.  Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.

Authors:  I Kjønniksen; P D Rye; O Fodstad
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

7.  Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.

Authors: 
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.